Arivin Therapeutics Oy
Finnish–Dutch biotech startup developing anti-virulence small-molecule therapies that neutralize bacterial toxins and disrupt biofilms to treat multidrug-resistant gram-negative infections; also developing a fast screening platform to identify candidates and advancing platform and pre-IND studies for indications such as chronic respiratory and wound infections.
Finanzierungsrunden
1
Gesamtvolumen
€3.0 Mio.
Letzte Runde
Seed
Investoren
2
Finanzierung nach Stage
Investoren (2)
Finanzierungsrunden
| Stage | Betrag | Investoren | Datum |
|---|---|---|---|
| Seed | €3.0 Mio. | 04. Sept. 2025 |
